Biotech · Private company
Adcendo ApS
Track this companyFree. Adds Adcendo ApS to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Antibody-drug conjugate (ADC)Phase 2 · Metastatic Soft Tissue SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- ADCE-B05Phase 1 · Solid Tumors (Phase 1)ClinicalTrials.gov · fetched Nov 12, 2026
- ADCE-T02Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- First-in-Human Study of ADCE-B05 in Patients With Advanced Solid TumorsPHASE1 · RECRUITING · started Mar 17, 2026ClinicalTrials.gov NCT07362888 · fetched Nov 12, 2026
- First-in-Human Study of ADCE-D01 in Soft Tissue SarcomaPHASE1_PHASE2 · RECRUITING · started Jun 5, 2025ClinicalTrials.gov NCT06797999 · fetched Nov 12, 2026
- ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid TumoursPHASE1 · RECRUITING · started Nov 25, 2024ClinicalTrials.gov NCT06597721 · fetched Nov 12, 2026